查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1754258

2025 年至 2033 年医疗外骨骼市场规模、份额、趋势及预测（按组件、类型、肢体、移动性、最终用户和地区）

Medical Exoskeleton Market Size, Share, Trends and Forecast by Component, Type, Extremity, Mobility, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球医疗外骨骼市场规模达4.9515亿美元。展望未来， IMARC Group预测，到2033年，该市场规模将达到55.2206亿美元，2025-2033年期间的复合年增长率为29.19%。目前，北美占据市场主导地位，2024年将占据36.5%的显着市场。投资和资金的增加推动了创新，使外骨骼更有效率、更方便。人工智慧(AI)和感测器技术的进步增强了即时运动适应能力，从而促进了更好的復健。监管部门的批准和保险覆盖确保了医疗外骨骼的安全性和可负担性，从而加速了市场份额的成长。

人口老化显着推动了医疗外骨骼市场的发展，增加了对行动辅助的需求。老年人面临更高的行动障碍风险，需要先进的日常活动支援解决方案。医疗外骨骼帮助老年人恢復行动能力，减少对照护者的依赖，并提高整体生活品质。关节炎和骨质疏鬆症等与年龄相关的疾病病例不断增加，进一步刺激了对穿戴式外骨骼的需求。这些设备能够增强稳定性并预防跌倒，解决老年人面临的主要行动障碍。医疗保健提供者越来越多地推荐外骨骼辅助康復，以改善老年患者受伤后的康復效果。轻量化和符合人体工学的外骨骼设计的进步提高了舒适度，使其适合长期使用。人工智慧驱动的自适应运动支援系统可提供个人化辅助，满足个人的行动需求。

不断成长的研发投入极大地推动了美国医疗外骨骼市场的需求。政府资金和私部门的投资正在加速创新外骨骼技术的发展。领先的研究机构和大学与製造商合作，增强用于復健的机器人移动解决方案。例如，2025 年 2 月，Wandercraft 启动了其个人外骨骼的关键临床试验，这是第一个供个人使用的自平衡设备。它专为行动不便人士设计，可恢復自然的步行动作。这项在詹姆斯彼得斯退伍军人医疗中心进行的试验将扩展到凯斯勒研究所，评估其对脊髓损伤的安全性和有效性。此外，外骨骼新创公司的风险投资正在促进竞争，从而带来具有成本效益和可扩展性的产品。美国国防部在外骨骼研究方面投入巨资，支持为受伤退伍军人和士兵提供应用。人工智慧驱动的运动控制和生物力学的进步提高了外骨骼的效率和自适应运动支援。医疗器材公司正专注于轻量化材料和节能设计，以提升使用者舒适度。 FDA 的批准和对穿戴式外骨骼的监管支持，确保了其更快的市场准入和更广泛的应用。

医疗外骨骼市场趋势：

穿戴式机器人技术的进步

穿戴式机器人技术的不断进步显着提升了医疗外骨骼的功能性、舒适性和适应性。科技进步使行动不便的使用者能够更有效率地运动、更耐用地生活，并获得个人化支援。轻量化材料、人工智慧驱动的运动控制和人体工学设计的创新提升了用户体验，使外骨骼在復健和日常使用中更加实用。现代外骨骼的设计旨在最大限度地减少身体压力，支持肌肉参与，同时促进自然的运动模式。这些改进有助于改善復健效果，使患有神经系统疾病、脊髓损伤和因年龄相关行动障碍的患者能够重获独立生活。先进的感测器技术和即时运动调节确保与使用者的身体运动无缝衔接。 2024年7月，Arc'teryx和Skip推出了MO/GO外骨骼健行裤，可减少40%的肌肉疲劳，支撑膝关节，并增强耐力。这项进展凸显了穿戴式外骨骼的广泛应用，展现了其在復健和行动辅助方面的潜力。

行动辅助需求不断成长

医疗外骨骼能够增强患者的独立性、改善其活动能力并提升生活质量，使其成为康復中心和个人用户的理想选择。这些设备可帮助使用者恢復运动能力，使他们能够更轻鬆地进行日常活动。配备人工智慧驱动的运动控制和基于感测器的自适应功能的先进机器人外骨骼进一步提升了用户体验。 2024年1月，哈佛大学和波士顿大学为帕金森氏症患者推出了一款软体机器人外骨骼，可减少跌倒并消除「僵住」现象。这款配备线缆驱动执行器和运动感测器的可穿戴外骨骼代表了神经系统疾病辅助移动技术的重大进步。随着关节炎、帕金森氏症和中风等与年龄相关的疾病日益增多，对增强运动能力和减少依赖性的辅助技术的需求也日益增长。

监管部门批准推动市场扩张

监管审批对于扩大医疗外骨骼市场、确保产品安全性、有效性和广泛应用至关重要。 FDA、CE 和加拿大卫生部等卫生部门的认证验证了外骨骼的性能，增强了消费者和医疗保健提供者的信心。随着越来越多的设备获得监管部门的批准，企业可以推出先进的復健和行动支援解决方案，从而促进市场成长。审批流程涉及严格的测试，以确保外骨骼符合安全标准并为行动不便的使用者提供有效的帮助。政府的措施和支持性政策进一步加快了监管审批，鼓励了医疗应用穿戴式机器人的创新。 2024 年 9 月，Human in Motion Robotics 获得批准在加拿大销售 XoMotion，这是世界上最先进的自平衡、免持医疗外骨骼。这款突破性的设备旨在帮助脊髓损伤、中风和神经系统疾病患者，代表了医疗外骨骼技术的重大飞跃。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球医疗外骨骼市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：按组成部分

  • 硬体
  • 软体

第七章：市场区隔：依类型

  • 动力外骨骼
  • 被动外骨骼

第八章：市场分化：极端状况

  • 下肢医疗外骨骼
  • 上肢医疗外骨骼
  • 全身

第九章：市场区隔：依移动性

  • 移动外骨骼
  • 固定式外骨骼

第十章：市场区隔：依最终用户

  • 復健中心
  • 物理治疗中心
  • 其他的

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • B-Temia Inc.
    • Cyberdyne Inc.
    • Ekso Bionics Holdings Inc.
    • ExoAtlet Global SA
    • GOGOA Mobility Robots
    • Hocoma AG (DIH International Limited)
    • Myomo Inc.
    • ReWalk Robotics Ltd
    • Rex Bionics Ltd.
    • suitX Inc. (Ottobock SE & Co. KGaA)
    • Wandercraft
    • Wearable Robotics Srl
Product Code: SR112025A6535

The global medical exoskeleton market size was valued at USD 495.15 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 5,522.06 Million by 2033, exhibiting a CAGR of 29.19% during 2025-2033. North America currently dominates the market, holding a significant market share of 36.5% in 2024. Increased investments and funding drive innovation, making exoskeletons more efficient and accessible. Advancements in artificial intelligence (AI) and sensor technology enhance real-time movement adaptation for better rehabilitation. Regulatory approvals and insurance coverage accelerate medical exoskeleton market share by ensuring safety and affordability.

The aging population is significantly driving the medical exoskeleton market by increasing demand for mobility assistance. Elderly individuals face higher risks of mobility impairments, requiring advanced solutions for daily movement support. Medical exoskeletons help seniors regain mobility, reducing dependence on caregivers and improving overall quality of life. Rising cases of age-related conditions like arthritis and osteoporosis further catalyzes the demand for wearable exoskeletons. These devices provide enhanced stability and fall prevention, addressing key mobility challenges among older adults. Healthcare providers increasingly recommend exoskeleton-assisted rehabilitation, improving recovery outcomes for elderly patients after injuries. Advancements in lightweight and ergonomic exoskeleton designs enhance comfort, making them suitable for extended use. AI-driven adaptive movement support systems allow personalized assistance, catering to individual mobility needs.

Growing investment in research and development (R&D) is significantly driving the United States medical exoskeleton market demand. Government funding and private sector investments are accelerating the development of innovative exoskeleton technologies. Leading research institutions and universities collaborate with manufacturers, enhancing robotic mobility solutions for rehabilitation. For instance, in February 2025, Wandercraft initiated a pivotal clinical trial for its Personal Exoskeleton, the first self-balancing device for personal use. Designed for individuals with severe mobility impairments, it restores natural walking motions. The trial, underway at the James J. Peters VA Medical Center, will expand to Kessler Institute, evaluating its safety and effectiveness for spinal cord injuries. Moreover, venture capital funding for exoskeleton startups is fostering competition, leading to cost-effective and scalable products. The US Department of Defense invests heavily in exoskeleton research, supporting applications for injured veterans and soldiers. Advancements in AI-driven motion control and biomechanics improve exoskeleton efficiency and adaptive movement support. Medical device companies are focusing on lightweight materials and energy-efficient designs, enhancing user comfort. FDA approvals and regulatory support for wearable exoskeletons ensure faster market entry and increased adoption.

Medical Exoskeleton Market Trends:

Advancements in Wearable Robotics Technology

Continuous advancements in wearable robotics are significantly improving the functionality, comfort, and adaptability of medical exoskeletons. Technological progress is enabling more efficient movement, increased durability, and personalized support for users with mobility impairments. Innovations in lightweight materials, AI-driven motion control, and ergonomic designs enhance user experience, making exoskeletons more practical for rehabilitation and daily use. Engineered to minimize physical strain, modern exoskeletons support muscle engagement while facilitating natural movement patterns. These enhancements contribute to improved rehabilitation outcomes, allowing patients with neurological disorders, spinal cord injuries, and age-related mobility challenges to regain independence. Advanced sensor technology and real-time motion adjustment ensure seamless integration with the user's body movements. In July 2024, Arc'teryx and Skip introduced MO/GO exoskeleton hiking pants, reducing muscle fatigue by 40%, supporting knee joints, and enhancing endurance. This development highlights the broader application of wearable exoskeletons, showcasing their potential for rehabilitation and mobility assistance.

Increasing Demand for Mobility Assistance

Medical exoskeletons provide greater independence, improved mobility, and enhanced quality of life, making them an attractive choice for both rehabilitation centers and personal use. These devices assist users in regaining movement, enabling them to perform daily activities with greater ease. Advanced robotic exoskeletons equipped with AI-driven motion control and sensor-based adaptability further improve user experience. In January 2024, Harvard and Boston University introduced a soft robotic exoskeleton for Parkinson's patients, reducing falls and eliminating "freezing" episodes. This wearable exoskeleton with cable-driven actuators and movement sensors represents a major advancement in assistive mobility technology for neurological disorders. As age-related disorders such as arthritis, Parkinson's disease, and stroke become more common, there is a growing need for assistive technologies that enhance movement and reduce dependency.

Regulatory Approvals Driving Market Expansion

Regulatory approvals are crucial for expanding the medical exoskeleton market, ensuring product safety, efficacy, and widespread adoption. Certification from health authorities such as the FDA, CE, and Health Canada validates the performance of exoskeletons, increasing consumer and healthcare provider confidence. As more devices receive regulatory clearance, companies can introduce advanced solutions for rehabilitation and mobility support, strengthening market growth. Approval processes involve rigorous testing, ensuring exoskeletons meet safety standards and deliver effective assistance for users with mobility impairments. Government initiatives and supportive policies further accelerate regulatory approvals, encouraging innovation in wearable robotics for healthcare applications. In September 2024, Human in Motion Robotics secured approval to market XoMotion, the world's most advanced self-balancing, hands-free medical exoskeleton, in Canada. This breakthrough device is designed to assist patients with spinal cord injuries, stroke, and neurological conditions, representing a significant leap in medical exoskeleton technology.

Medical Exoskeleton Industry Segmentation:

Analysis by Component:

  • Hardware
  • Software

Hardware leads the market with 84.0% of market share in 2024. Critical components like sensors, actuators, and power systems contribute significantly to exoskeleton performance and cost. Advanced motion sensors and AI-driven controllers enhance mobility assistance, ensuring precise movement adaptation for users. Lightweight yet durable materials like carbon fiber and titanium improve comfort and long-term usability. High-performance actuators and motors provide necessary force, enabling exoskeletons to assist movement efficiently. Battery advancements play a crucial role, as improved power efficiency extends operational time for continuous mobility support. The high cost of developing and manufacturing hardware makes it the largest revenue-generating segment in the market. Manufacturers focus on hardware improvements, integrating miniaturized components to enhance wearability and comfort. Hardware components undergo rigorous testing and regulatory approvals, further increasing development costs and market share. Innovations in biomechanical engineering ensure seamless interaction between exoskeleton hardware and the human body. Increasing demand for robotic rehabilitation solutions drives continuous improvements in hardware technologies.

Analysis by Type:

  • Powered Exoskeletons
  • Passive Exoskeletons

Powered exoskeletons lead the market with 87.8% of market share in 2024. These systems use electric motors, hydraulics, or pneumatics, providing active support for users with mobility impairments. AI-driven control systems enable real-time movement adjustments, ensuring adaptive support based on user needs. Rehabilitation centers and hospitals prefer powered exoskeletons, as they offer enhanced gait training for patients. Advanced battery technologies improve operational efficiency, reducing downtime and increasing user independence. The increasing prevalence of neurological disorders and spinal cord injuries drives demand for powered exoskeletons. Their ability to generate mechanical force makes them ideal for individuals with severe mobility challenges. Ongoing advancements in robotic exoskeletons continue to improve weight distribution and comfort for extended wear. Rising government support and insurance reimbursements make powered exoskeletons more accessible for medical and personal use. Leading manufacturers focus on developing lightweight, high-performance exoskeletons, expanding their application in healthcare. Wearable robotics innovations enhance energy efficiency, making powered exoskeletons more practical for daily use. The growing demand for automated rehabilitation solutions further cements powered exoskeletons as the leading market segment.

Analysis by Extremity:

  • Lower Extremity Medical Exoskeletons
  • Upper Extremity Medical Exoskeletons
  • Full Body

Lower extremity medical exoskeletons dominate the market with 52.6% of market share in 2024. Patients with spinal cord injuries, stroke, and neuromuscular disorders benefit significantly from lower limb exoskeletons. These devices enhance gait training, allowing individuals to regain walking ability through rehabilitation therapy. Hospitals and rehabilitation centers widely adopt lower extremity exoskeletons, increasing their market demand. Improved biomechanical engineering ensures seamless movement synchronization, enhancing user comfort and efficiency. The rising geriatric population further increases demand for lower limb support solutions. These exoskeletons reduce the risk of falls, improving mobility in elderly and disabled individuals. Technological advancements in motorized knee and hip support enhance functionality and ease of use. AI-driven motion assistance provides personalized support, ensuring adaptive rehabilitation therapy for users. The high cost of lower extremity exoskeletons reflects the complexity of their mechanics and design. Healthcare professionals prioritize lower limb exoskeletons, as walking rehabilitation is a primary focus in physical therapy. Research in lightweight and energy-efficient materials continues to improve lower extremity exoskeleton performance.

Analysis by Mobility:

  • Mobile Exoskeletons
  • Stationary Exoskeletons

Mobile exoskeletons are gaining traction due to their ability to provide real-time mobility assistance for users. These devices allow individuals with spinal cord injuries, stroke, or neurological disorders to regain independent movement. Advancements in AI-driven motion control and lightweight materials enhance comfort and adaptability. Rehabilitation centers and home users increasingly adopt mobile exoskeletons for daily mobility support. Battery efficiency and wireless connectivity improvements further enhance their practicality.

Stationary exoskeletons are widely used in rehabilitation centers for controlled therapy and muscle reactivation. These devices provide targeted assistance for patients recovering from spinal cord injuries, stroke, or musculoskeletal disorders. Healthcare professionals prefer stationary exoskeletons for supervised gait training and muscle strengthening programs. Advanced robotics and sensor technologies enable precise movement patterns, improving rehabilitation outcomes. Government initiatives and insurance coverage for robotic therapy support market growth. Hospitals and therapy centers continue investing in stationary exoskeletons for structured rehabilitation programs.

Analysis by End User:

  • Rehabilitation Centers
  • Physiotherapy Centers
  • Others

Rehabilitation centers lead the market with 50.7% of market share in 2024. These facilities integrate exoskeletons into therapy programs, helping patients regain mobility after injuries. Exoskeleton-assisted rehabilitation improves walking ability, making it a preferred solution for physical therapy. Rising cases of spinal cord injuries and stroke-related mobility issues drive demand for rehabilitation services. Medical professionals use exoskeletons for gait training, enhancing patient recovery outcomes. Hospitals and clinics partner with exoskeleton manufacturers, ensuring access to the latest rehabilitation technologies. Government healthcare initiatives support rehabilitation programs, increasing market growth for medical exoskeletons. Advanced AI-driven rehabilitation exoskeletons offer personalized therapy, improving patient progress tracking. Higher insurance reimbursements for exoskeleton-based therapy encourage rehabilitation centers to invest in this technology. Continuous research and development (R&D) in robotic rehabilitation solutions ensures exoskeletons remain an essential part of physiotherapy. The increasing focus on patient-centered care drives the adoption of medical exoskeletons in therapy.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of 36.5%. The United States and Canada invest heavily in medical robotics, accelerating exoskeleton research and development (R&D). Government initiatives and funding for assistive technologies fuels the market growth in the region. Leading medical exoskeleton manufacturers are headquartered in North America, strengthening the market landscape. High prevalence of spinal cord injuries and neurological disorders increases demand for mobility assistance solutions. Strong collaborations between research institutions and healthcare providers drive exoskeleton innovation and adoption. Expanding insurance coverage for exoskeleton-assisted rehabilitation enhances patient accessibility in the region. Military and defense research on wearable robotics further contributes to market expansion. Artificial intelligence (AI) and Internet of Things (IoT)-driven advancements in medical robotics position North America as a global leader in exoskeleton technology. Rising geriatric population and mobility impairments increase the demand for advanced rehabilitation solutions. Widespread presence of rehabilitation centers and hospitals accelerates medical exoskeleton integration into therapy. Venture capital investments in healthcare robotics startups fuel market expansion. Continuous technological improvements in wearable robotics strengthen North America's dominance.

Key Regional Takeaways:

United States Medical Exoskeleton Market Analysis

The United States hold 91.10% of the market share in North America. The rising incidence of spinal cord injuries and work-related musculoskeletal disorders is significantly accelerating the growth of the market. According to the National Spinal Cord Injury Statistical Center (NSCISC), approximately 17,730 new spinal cord injuries are diagnosed annually in the US, with nearly 291,000 individuals currently living with SCIs. These injuries often lead to long-term mobility impairments, increasing the need for effective rehabilitation solutions such as medical exoskeletons. Workplace injuries further contribute to market expansion, with musculoskeletal disorders being a major concern across industries. The US Bureau of Labor Statistics reported 502,380 cases of occupational musculoskeletal disorders in 2022, highlighting the growing demand for assistive mobility technologies to aid recovery. As more workers require advanced rehabilitation solutions, the adoption of medical exoskeletons continues to rise. Market growth is further supported by technological advancements in robotic exoskeletons, favorable insurance policies, and increased healthcare funding. Expanding research efforts, AI-driven innovations, and greater accessibility to rehabilitation technologies are expected to drive significant market expansion. With ongoing developments in wearable robotics and increasing support for mobility assistance, the US medical exoskeleton market outlook is set for substantial growth in the coming years.

Asia Pacific Medical Exoskeleton Market Analysis

The Asia Pacific market is expanding rapidly, driven by technological advancements and growing collaborations in assistive mobility solutions. In June 2022, CYBERDYNE Inc. partnered with Malaysia's Social Security Organization (SOCSO) to expand Cybernics Treatment using its Hybrid Assistive Limb (HAL) exoskeleton. This initiative has increased access to robotic rehabilitation for SOCSO-insured patients, accelerating the adoption of medical exoskeletons across Southeast Asia. India's health tech sector is also advancing in robotic exoskeleton development, contributing to regional market growth. In 2020, GenElek Technologies, a New Delhi-based startup, introduced an advanced robotic exoskeleton designed to assist individuals with mobility impairments. The rising prevalence of spinal cord injuries, neurological disorders, and workplace-related musculoskeletal conditions is further driving demand. Increasing government support, healthcare investments, and the expansion of rehabilitation facilities integrating exoskeleton technology are strengthening the market growth. Innovations in AI-driven mobility solutions and improvements in affordability are making exoskeletons more accessible across the region.

Europe Medical Exoskeleton Market Analysis

The rising prevalence of neurological diseases is a key driver of the Europe market, fueling demand for assistive mobility solutions. According to the European Academy of Neurology (EAN), one in three people worldwide experience a neurological disorder in their lifetime. Conditions such as stroke, multiple sclerosis, Parkinson's disease, and spinal cord injuries significantly impact mobility, increasing the need for advanced rehabilitation technologies in Europe. Medical exoskeletons enhance mobility and independence, playing a vital role in neurological rehabilitation and long-term care. European governments and healthcare providers are heavily investing in robotic-assisted therapy, recognizing its benefits for patient recovery. Advancements in AI-powered exoskeletons and wearable robotics are further driving innovation and adoption across the region. Supportive reimbursement policies and growing integration of exoskeletons in hospitals and rehabilitation centers are strengthening market expansion. As neurological disorders continue to rise, the demand for cutting-edge medical exoskeletons is expected to grow. With continuous technological progress and increased healthcare funding, the Europe medical exoskeleton market is poised for substantial long-term growth.

Latin America Medical Exoskeleton Market Analysis

The rapidly aging population in Latin America is a major driver inducing growth in the medical exoskeleton market. Industry reports show that Brazil's population aged 65 and older grew by 57%, increasing from 14.1 million in 2010 to 22.2 million in 2022. This demographic now comprises 11% of the total population, with another 10 million individuals aged 60-65 requiring mobility assistance. Age-related conditions such as stroke, arthritis, and neurodegenerative disorders are further driving demand for assistive robotic exoskeletons. Governments and healthcare providers in Brazil, Mexico, and Argentina are investing in advanced rehabilitation technologies to enhance mobility solutions for elderly individuals. Expanding healthcare infrastructure and rising public awareness are contributing to greater adoption of wearable exoskeletons. AI-powered robotics and smart rehabilitation systems are further revolutionizing elderly care, making exoskeletons more effective and accessible.

Middle East and Africa Medical Exoskeleton Market Analysis

The Middle East and Africa region market is expanding due to rising investments in robotic technologies and healthcare applications. The growing adoption of exoskeletons in rehabilitation centers and hospitals is propelling market growth across the region. In February 2021, Paramount Group and Sarcos Robotics signed an agreement to introduce advanced robotic systems for defense and industrial use. This initiative has paved the way for integrating exoskeleton technology into medical and assistive mobility solutions. The increasing prevalence of spinal cord injuries, stroke, and musculoskeletal disorders has intensified the need for robotic rehabilitation devices. Governments in the region are investing in healthcare infrastructure and promoting awareness of assistive technologies, further accelerating market expansion. International collaborations with leading exoskeleton manufacturers are enhancing accessibility to cutting-edge wearable robotics. As technological advancements continue, medical exoskeleton adoption is expected to rise across the Middle East and Africa.

Competitive Landscape:

Major companies are spending immensely in research and development (R&D) to improve exoskeleton efficiency, comfort, and functionality. Strategic partnerships between medical device firms and technology companies accelerate advancements in AI-driven mobility solutions. Moreover, AI-powered exoskeletons are transforming rehabilitation by enhancing mobility for individuals with spinal cord injuries and neurological conditions. To expand the horizon of AI integration, Ekso Bionics hosted a webinar in November 2024. Katherine Strausser, Principal Controls Engineer, joined the AI for Good webinar, "AI-powered Exo skeletons Revolutionizing Rehabilitation and Mobility". The session discusses advancements in exoskeleton technology and its impact on medical rehabilitation. Interested participants can register online. Additionally, major manufacturers are focusing on lightweight materials and ergonomic designs, enhancing user experience and long-term wearability. Continuous product innovation by key players ensures medical exoskeletons meet evolving rehabilitation and mobility assistance needs. Collaborations with healthcare providers and rehabilitation centers expand exoskeleton accessibility for patients with mobility impairments. Key players prioritize regulatory compliance and safety standards, ensuring approval from government agencies like FDA and CE. Expanding production capabilities and distribution networks allow companies to penetrate emerging markets and increase adoption. Investments in AI and sensor technology enhance real-time movement adaptation, providing personalized support for users.

The report provides a comprehensive analysis of the competitive landscape in the medical exoskeleton market with detailed profiles of all major companies, including:

  • B-Temia Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings Inc.
  • ExoAtlet Global S.A.
  • GOGOA Mobility Robots
  • Hocoma AG (DIH International Limited)
  • Myomo Inc.
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • suitX Inc. (Ottobock SE & Co. KGaA)
  • Wandercraft
  • Wearable Robotics Srl

Key Questions Answered in This Report

  • 1.How big is the medical exoskeleton market?
  • 2.What is the future outlook of medical exoskeleton market?
  • 3.What are the key factors driving the medical exoskeleton market?
  • 4.Which region accounts for the largest medical exoskeleton market share?
  • 5.Which are the leading companies in the global medical exoskeleton market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Medical Exoskeleton Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Hardware
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Software
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Powered Exoskeletons
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Passive Exoskeletons
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Extremity

  • 8.1 Lower Extremity Medical Exoskeletons
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Upper Extremity Medical Exoskeletons
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Full Body
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Mobility

  • 9.1 Mobile Exoskeletons
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stationary Exoskeletons
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Rehabilitation Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Physiotherapy Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 B-Temia Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Cyberdyne Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Ekso Bionics Holdings Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 ExoAtlet Global S.A.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 GOGOA Mobility Robots
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Hocoma AG (DIH International Limited)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Myomo Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 ReWalk Robotics Ltd
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
    • 16.3.9 Rex Bionics Ltd.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 suitX Inc. (Ottobock SE & Co. KGaA)
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Wandercraft
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Wearable Robotics Srl
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Medical Exoskeleton Market: Major Drivers and Challenges
  • Figure 2: Global: Medical Exoskeleton Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Medical Exoskeleton Market: Breakup by Component (in %), 2024
  • Figure 5: Global: Medical Exoskeleton Market: Breakup by Type (in %), 2024
  • Figure 6: Global: Medical Exoskeleton Market: Breakup by Extremity (in %), 2024
  • Figure 7: Global: Medical Exoskeleton Market: Breakup by Mobility (in %), 2024
  • Figure 8: Global: Medical Exoskeleton Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Medical Exoskeleton Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Medical Exoskeleton (Hardware) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Medical Exoskeleton (Hardware) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Medical Exoskeleton (Software) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Medical Exoskeleton (Software) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Medical Exoskeleton (Powered Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Medical Exoskeleton (Powered Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Medical Exoskeleton (Passive Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Medical Exoskeleton (Passive Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Medical Exoskeleton (Lower Extremity Medical Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Medical Exoskeleton (Lower Extremity Medical Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Medical Exoskeleton (Upper Extremity Medical Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Medical Exoskeleton (Upper Extremity Medical Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Medical Exoskeleton (Full Body) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Medical Exoskeleton (Full Body) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Medical Exoskeleton (Mobile Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Medical Exoskeleton (Mobile Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Medical Exoskeleton (Stationary Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Medical Exoskeleton (Stationary Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Medical Exoskeleton (Rehabilitation Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Medical Exoskeleton (Rehabilitation Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Medical Exoskeleton (Physiotherapy Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Medical Exoskeleton (Physiotherapy Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Medical Exoskeleton (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Medical Exoskeleton (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Medical Exoskeleton Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Medical Exoskeleton Industry: SWOT Analysis
  • Figure 84: Global: Medical Exoskeleton Industry: Value Chain Analysis
  • Figure 85: Global: Medical Exoskeleton Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Medical Exoskeleton Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Medical Exoskeleton Market Forecast: Breakup by Component (in Million USD), 2025-2033
  • Table 3: Global: Medical Exoskeleton Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 4: Global: Medical Exoskeleton Market Forecast: Breakup by Extremity (in Million USD), 2025-2033
  • Table 5: Global: Medical Exoskeleton Market Forecast: Breakup by Mobility (in Million USD), 2025-2033
  • Table 6: Global: Medical Exoskeleton Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Medical Exoskeleton Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Medical Exoskeleton Market: Competitive Structure
  • Table 9: Global: Medical Exoskeleton Market: Key Players